Literature DB >> 18432936

B cell epitope mapping using synthetic peptides.

John Mark Carter1, Larry Loomis-Price.   

Abstract

Synthetic peptides are used for identification of functional B cell epitopes in antibody preparations. ELISA-type assays are used to identify sequences of proteins comprising antibody-binding regions. This unit describes three peptide display formats. Pepscan (pins) and SPOTs (cellulose membranes) may be used as solid-phase support media for peptide synthesis, followed by ELISA directly on the resulting peptide array. Alternatively, peptides may be cleaved from the array and tested in a standard microplate-based antibody capture ELISA format. The discussion includes choosing the peptide sequences by length and overlap, as well as determination of the minimum essential sequence for antibody binding. This method is highly effective for continuous epitopes and is often also useful for discontinuous epitopes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 18432936     DOI: 10.1002/0471142735.im0904s60

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  10 in total

1.  Epitope mapping in cell surface proteins by site-directed masking: defining the structural elements of NTPDase3 inhibition by a monoclonal antibody.

Authors:  Vasily V Ivanenkov; Patrick A Crawford; Aimi Toyama; Jean Sévigny; Terence L Kirley
Journal:  Protein Eng Des Sel       Date:  2010-05-27       Impact factor: 1.650

2.  Misfolded proteins induce aggregation of the lectin Yos9.

Authors:  Melanie H Smith; Edwin H Rodriguez; Jonathan S Weissman
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

Review 3.  Immunity to ricin: fundamental insights into toxin-antibody interactions.

Authors:  Joanne M O'Hara; Anastasiya Yermakova; Nicholas J Mantis
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 4.  Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects.

Authors:  Salvador Eugenio C Caoili
Journal:  J Biomed Biotechnol       Date:  2010-03-30

Review 5.  Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics.

Authors:  Satoshi Nagata; Ira Pastan
Journal:  Adv Drug Deliv Rev       Date:  2009-08-11       Impact factor: 15.470

6.  Epitope Mapping of Antibody-Antigen Interactions with X-Ray Crystallography.

Authors:  Moeko Toride King; Cory L Brooks
Journal:  Methods Mol Biol       Date:  2018

7.  Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis.

Authors:  Guanghui Zhao; Aihua Zhou; Gang Lv; Min Meng; Min Sun; Yang Bai; Yali Han; Lin Wang; Huaiyu Zhou; Hua Cong; Qunli Zhao; Xing-Quan Zhu; Shenyi He
Journal:  BMC Infect Dis       Date:  2013-05-07       Impact factor: 3.090

8.  Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.

Authors:  Rongmao Zhao; Shujuan Cui; Li Guo; Chao Wu; Richard Gonzalez; Gláucia Paranhos-Baccalà; Guy Vernet; Jianwei Wang; Tao Hung
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

9.  Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.

Authors:  Andrew K I Falconar
Journal:  BMC Res Notes       Date:  2012-07-05

10.  An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer's disease: pyroglutamate amyloid beta.

Authors:  M Vukicevic; E Fiorini; S Siegert; R Carpintero; M Rincon-Restrepo; P Lopez-Deber; N Piot; M Ayer; I Rentero; C Babolin; S Bravo-Veyrat; V Giriens; C Morici; M Beuzelin; A Gesbert; S Rivot; S Depretti; P Donati; J Streffer; A Pfeifer; M H Kosco-Vilbois
Journal:  Brain Commun       Date:  2022-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.